Welcome to LookChem.com Sign In|Join Free
  • or
Tert-butyl (6-oxoheptyl)carbamate is a carbamate family chemical compound, derived from tert-butyl carbamate, and features a 6-oxoheptyl substituent that introduces a seven-carbon chain with a ketone group. This structural modification endows the molecule with enhanced flexibility and reactivity, making it a valuable synthetic intermediate in organic chemistry. Its carbamoylating properties and potential in drug discovery and the synthesis of bioactive compounds highlight its significance in both pharmaceutical and agrochemical industries.

128372-98-5

Post Buying Request

128372-98-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128372-98-5 Usage

Uses

Used in Organic Chemistry:
Tert-butyl (6-oxoheptyl)carbamate is used as a synthetic intermediate for its ability to act as a carbamoylating agent, facilitating various organic chemistry reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tert-butyl (6-oxoheptyl)carbamate is used as a precursor in drug discovery and development, owing to its potential to contribute to the synthesis of bioactive compounds.
Used in Agrochemicals:
Tert-butyl (6-oxoheptyl)carbamate also finds application in agrochemicals, where it serves as a key intermediate in the synthesis of active ingredients for pesticides and other agricultural chemicals, leveraging its reactivity and structural attributes.

Check Digit Verification of cas no

The CAS Registry Mumber 128372-98-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,3,7 and 2 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 128372-98:
(8*1)+(7*2)+(6*8)+(5*3)+(4*7)+(3*2)+(2*9)+(1*8)=145
145 % 10 = 5
So 128372-98-5 is a valid CAS Registry Number.

128372-98-5Downstream Products

128372-98-5Relevant academic research and scientific papers

HDAC INHIBITORS

-

Page/Page column 30-32, (2009/04/25)

The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.

Reductive deamination of α-amino carbonyl compounds by means of samarium iodide

Honda, Toshio,Ishikawa, Fumihiro

, p. 1065 - 1066 (2007/10/03)

Reaction of α-amino carbonyl compounds with SmI2 in THF-HMPA in the presence of a proton source afforded the deamination products, where the fragmentation occurred between the nitrogen and the carbon α to the carbonyl group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 128372-98-5